Organoid systems enable accurate, personalized predictions for drug interaction, efficacy, and toxicity, and can model systemic disease states.

“This approach enables accurate, personalized, case-by-case predictions for drug interaction, efficacy, and toxicity. These systems can even model systemic disease states, such as blood-brain barrier permeability, neurotoxicity, lung and pancreas cystic fibrosis, cancer metastasis, and responsiveness to chemotherapy.”